DE3302949C2 - - Google Patents
Info
- Publication number
- DE3302949C2 DE3302949C2 DE3302949A DE3302949A DE3302949C2 DE 3302949 C2 DE3302949 C2 DE 3302949C2 DE 3302949 A DE3302949 A DE 3302949A DE 3302949 A DE3302949 A DE 3302949A DE 3302949 C2 DE3302949 C2 DE 3302949C2
- Authority
- DE
- Germany
- Prior art keywords
- administration
- nasal
- dihydroergotamine
- caffeine
- theophylline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8202781 | 1982-02-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3302949A1 DE3302949A1 (de) | 1983-08-11 |
| DE3302949C2 true DE3302949C2 (US20100056889A1-20100304-C00004.png) | 1992-05-21 |
Family
ID=10528017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19833302949 Granted DE3302949A1 (de) | 1982-02-01 | 1983-01-29 | Nasal verabreichbare pharmazeutische zusammensetzungen |
Country Status (27)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0715285D0 (en) * | 2007-08-06 | 2007-09-12 | Britannia Pharmaceuticals Ltd | Improvements in or relating to powdered medicaments for nasal delivery |
| GB0910375D0 (en) * | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
| CN111936140A (zh) * | 2018-01-05 | 2020-11-13 | 英倍尔药业股份有限公司 | 通过精密鼻装置的双氢麦角胺的鼻内递送 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3091569A (en) * | 1960-08-26 | 1963-05-28 | Mead Johnson & Co | Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus |
| GB1202885A (en) * | 1966-12-22 | 1970-08-19 | Sandoz Ltd | Pharmaceutical compositions comprising alkaloids |
| DE2750090A1 (de) * | 1976-11-19 | 1978-06-01 | Sandoz Ag | Neue verabreichungsformen fuer organische verbindungen |
| FR2387035A1 (fr) * | 1977-04-12 | 1978-11-10 | Cassenne Lab Sa | Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux |
| DE2831728C2 (de) * | 1978-07-19 | 1982-12-23 | Krewel-Werke Gmbh, 5208 Eitorf | Arzneimittel zur Behandlung von Kopfschmerzen |
-
1983
- 1983-01-25 FI FI830245A patent/FI81258C/fi not_active IP Right Cessation
- 1983-01-27 FR FR8301228A patent/FR2539994B1/fr not_active Expired
- 1983-01-28 NL NL8300325A patent/NL192325C/nl not_active IP Right Cessation
- 1983-01-28 CH CH495/83A patent/CH653555A5/de not_active IP Right Cessation
- 1983-01-28 NZ NZ203117A patent/NZ203117A/en unknown
- 1983-01-28 AU AU10850/83A patent/AU565613B2/en not_active Expired
- 1983-01-28 PH PH28445A patent/PH22198A/en unknown
- 1983-01-29 DE DE19833302949 patent/DE3302949A1/de active Granted
- 1983-01-31 PT PT76166A patent/PT76166B/pt unknown
- 1983-01-31 IE IE187/83A patent/IE54532B1/en not_active IP Right Cessation
- 1983-01-31 DK DK038183A patent/DK164771C/da not_active IP Right Cessation
- 1983-01-31 SE SE8300495A patent/SE454402B/sv not_active IP Right Cessation
- 1983-01-31 CA CA000420539A patent/CA1197783A/en not_active Expired
- 1983-01-31 AT AT0030383A patent/AT385656B/de not_active IP Right Cessation
- 1983-01-31 JP JP58015392A patent/JPS58134017A/ja active Granted
- 1983-01-31 BE BE1/10708A patent/BE895750A/fr not_active IP Right Cessation
- 1983-01-31 GR GR70362A patent/GR81320B/el unknown
- 1983-01-31 HU HU83323A patent/HU191512B/hu unknown
- 1983-01-31 LU LU84613A patent/LU84613A1/fr unknown
- 1983-02-01 IT IT47646/83A patent/IT1197558B/it active
- 1983-02-01 ES ES519450A patent/ES519450A0/es active Granted
- 1983-02-01 IL IL67822A patent/IL67822A/xx not_active IP Right Cessation
- 1983-02-01 ZA ZA83673A patent/ZA83673B/xx unknown
-
1987
- 1987-12-30 MY MY766/87A patent/MY8700766A/xx unknown
-
1989
- 1989-05-25 SG SG343/89A patent/SG34389G/en unknown
- 1989-06-21 KE KE3888A patent/KE3888A/xx unknown
- 1989-07-27 HK HK599/89A patent/HK59989A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69526425T2 (de) | Verwendung von mometasone-furoat zur behandlung von luftweg- und lungenerkrankungen | |
| EP1283036B1 (de) | Multidosis-Trockenpulverinhalator mit Pulverreservoir | |
| DE69108200T2 (de) | 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indol-5-methansulfonamid Sulfat (2:1). | |
| EP1121112B1 (de) | Lagerfähiges wirkstoffkonzentrat mit formoterol | |
| EP0316633B1 (de) | Azelastin enthaltende Arzneimittel zur Anwendung in der Nase und/oder am Auge | |
| DE69822665T2 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
| DE69528769T2 (de) | Aerosolformulierung für arzneimittel enthaltend polyglycolisierte glyzeride | |
| DE69802097T2 (de) | Eletriptanhemisulfat und kaffein enthaltende pharmazeutische zusammenstellungen | |
| DE3335086C2 (US20100056889A1-20100304-C00004.png) | ||
| DE69018092T2 (de) | Aerosolzubereitung von glutathion und verfahren zur erhöhung des glutathionspiegels in der lunge. | |
| DE1492015A1 (de) | Verbesserte Verabreichungsform pharmazeutischer Praeparate | |
| DE2851543A1 (de) | Inhalationspraeparat | |
| DE60002885T2 (de) | Wässrige formulierung zur nasalen verabreichung | |
| EP0214620B1 (de) | Transdermale Applikationsform von Diltiazem | |
| DE10337186A1 (de) | Wässrige Wirkstoff-Lösung | |
| DE69229688T4 (de) | Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten | |
| DE3527587A1 (de) | Nasale zubereitungen | |
| DE3302949C2 (US20100056889A1-20100304-C00004.png) | ||
| DE69030584T2 (de) | Verfahren sowie zusammensetzungen zur behandlung mit vitaminmineral | |
| DE69015890T2 (de) | Aerosole von Pyrido(1,2-a)pyrimidinen. | |
| EP0529499A1 (de) | Pharmazeutische Zusammensetzungen enthaltend Bradykinin-Antagonisten zur lokalen Anwendung an Nase und Auge | |
| DE68912947T2 (de) | Ein lösliches ibopamin-salz enthaltende augenarzneizubereitung. | |
| DE3882353T2 (de) | Hustenstillende Zusammensetzungen und ein Verfahren zu deren Herstellung. | |
| DE10014007A1 (de) | Neue Darreichungsformen für DSIP | |
| AT402895B (de) | Verfahren zur herstellung einer flüssigen pharmazeutischenzusammensetzung für die nasale verabreichung eines calcitonins als nasaler spray |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8125 | Change of the main classification |
Ipc: A61K 31/52 |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: NOVARTIS AG, BASEL, CH |
|
| 8328 | Change in the person/name/address of the agent |
Free format text: SPOTT WEINMILLER & PARTNER, 80336 MUENCHEN |